Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.

JNCI Cancer Spectr · 2020 · PMC7050148 · PMID 32296755

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This showed a trend toward higher overall survival in patients with lower CatD values, especially in gemcitabine-treated patients ( Supplementary Figure 2A , available online).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.